PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase
about
PPARs and the cardiovascular systemPPAR-γ -- a possible drug target for complicated pregnanciesRosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cellscAMP-stimulated transcription of DGKθ requires steroidogenic factor 1 and sterol regulatory element binding protein 1Mechanisms by which diabetes increases cardiovascular disease.Renoprotective effect of rosiglitazone through the suppression of renal intercellular adhesion molecule-1 expression in streptozotocin-induced diabetic rats.The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.A PPARγ-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis.Effect of peroxisome proliferator-activated receptor gamma agonist (pioglitazone) and methotrexate on disease activity in rheumatoid arthritis (experimental and clinical study).Suppression of cardiac myocyte hypertrophy by conjugated linoleic acid: role of peroxisome proliferator-activated receptors alpha and gamma.Diacylglycerol Kinase Inhibition and Vascular FunctionPioglitazone restores IGFBP-3 levels through DNA PK in retinal endothelial cells cultured in hyperglycemic conditions.Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism.PPAR ligands: are they potential agents for cardiovascular disorders?The complications of promiscuity: endocannabinoid action and metabolismDoes peroxisome proliferator-activated receptor-gamma (PPAR gamma) protect from hypertension directly through effects in the vasculature?Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease.Roles of lipid-modulating enzymes diacylglycerol kinase and cyclooxygenase under pathophysiological conditions.PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/macrophages.PPARγ activation inhibits cerebral arteriogenesis in the hypoperfused rat brain.Preparation of low density lipoprotein from large apheresis cartridges for induction of cell death in Saos2 osteoblasts.PPARG gene C161T CT/TT associated with lower blood lipid levels and ischemic stroke from large-artery atherosclerosis in a Han population in Guangdong.PPARgamma and Agonists against Cancer: Rational Design of Complementation Treatments.Protective Actions of PPAR-gamma Activation in Renal Endothelium.Rosiglitazone improves aortic arginine transport, through inhibition of PKCalpha, in uremic rats.Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.Diacylglycerol kinase α deficiency alters inflammation markers in adipose tissue in response to high fat diet.Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.Salusin-β Is Involved in Diabetes Mellitus-Induced Endothelial Dysfunction via Degradation of Peroxisome Proliferator-Activated Receptor Gamma.Effects of telmisartan and pioglitazone on high fructose induced metabolic syndrome in rats.Peroxisome proliferator-activated receptor γ agonists attenuate hyperglycaemia-induced hyaluronan secretion in vascular smooth muscle cells by inhibiting PKCβ2.
P2860
Q24642728-B2B0775C-F8C3-4E2B-9A1D-F4CB4375DB16Q26863678-D4D6E159-45FD-49DE-9FCE-C5BC8C069940Q27309387-AA2C0D39-ED7F-4065-90C6-04B9206707A9Q28115537-166A17D6-6207-4D5D-A114-D1F18B025004Q30441275-970C6D87-DB78-4B2B-B831-E4476AFFC4EAQ33413024-F02B031B-FB5E-4D91-8D00-C81B127A028FQ33561725-228701F8-282A-45E4-9151-DD27DF9CE059Q33746963-FAF6B907-55BC-4A48-922B-1EAD304D0A93Q34578619-DBE89030-1BEB-492D-B3BD-A6F1365FE4DDQ34751805-7006FF9A-DAF7-46BE-A346-0189B5D1A3EBQ34914993-CEFD9F8B-1896-4FF9-AC9F-89AF4FE4279CQ34956067-57AED7E2-E201-4F42-8EDD-0EFEC2F101E6Q35636191-C904A75C-2FB7-43E8-91C9-D8C586C5F74DQ36640675-C45A6F2C-580B-4934-9D15-B1A8FF360BA9Q36819094-8C773E89-39D2-4698-8B0C-D2461B1CBB94Q36944706-3D82EDDD-63D6-4809-8BD8-864CF16D5117Q37686890-70291BB2-087C-475C-AE3E-7049FE2094A3Q37943863-4FD93638-DB8D-43EB-B473-6502C429D918Q38282568-21B72326-0874-4659-AC73-39E1F4661CDEQ39733531-F474E8C2-68FE-4AC8-AA8D-D53C2BA49D30Q40143324-496078B5-05DD-4B41-AA39-F547DB08AF54Q40260061-319C3874-C241-4189-8933-3B5B86B86D46Q40717921-78FD8BFF-0342-4C28-B634-2CBEDDA69E1FQ41677812-07185402-CD6F-465B-8D84-400D36FD5EA8Q42008239-08E9E375-BF04-439A-824E-7B049E961F77Q46558857-9C158AFE-5EFE-4009-98E5-20AF8F41BD3DQ46905338-7A393B0B-EFD0-48CC-B781-AB90140741BDQ47300958-55C7FBE7-0C23-4957-BAB9-71418B7E9159Q47739408-40C7FA2C-C6A4-4C9E-84AE-F776351FA060Q48189441-9FA779FD-92B2-4AD6-BB54-0397DB26B5B5Q51283845-A79C476F-9849-4018-934F-47A2C93CBEB3Q54444900-97409486-DF54-48ED-80FE-3498E789B02D
P2860
PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
PPARgamma agonists ameliorate ...... role of diacylglycerol kinase
@ast
PPARgamma agonists ameliorate ...... role of diacylglycerol kinase
@en
PPARgamma agonists ameliorate ...... role of diacylglycerol kinase
@nl
type
label
PPARgamma agonists ameliorate ...... role of diacylglycerol kinase
@ast
PPARgamma agonists ameliorate ...... role of diacylglycerol kinase
@en
PPARgamma agonists ameliorate ...... role of diacylglycerol kinase
@nl
prefLabel
PPARgamma agonists ameliorate ...... role of diacylglycerol kinase
@ast
PPARgamma agonists ameliorate ...... role of diacylglycerol kinase
@en
PPARgamma agonists ameliorate ...... role of diacylglycerol kinase
@nl
P2093
P1433
P1476
PPARgamma agonists ameliorate ...... role of diacylglycerol kinase
@en
P2093
Chris Hahn
Emily Verrier
Jennifer R Gamble
Lijun Wang
Mathew A Vadas
Nathaniel Albanese
V Krishna K Chatterjee
P304
P356
10.1161/01.RES.0000130527.92537.06
P407
P50
P577
2004-04-29T00:00:00Z